CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,554 | +1.5% | 72,406 | +77.9% | 0.00% | – |
| Q2 2023 | $48,843 | +5.3% | 40,703 | +2.7% | 0.00% | – |
| Q1 2023 | $46,390 | +28.3% | 39,650 | -13.1% | 0.00% | – |
| Q4 2022 | $36,160 | -17.8% | 45,650 | +24.6% | 0.00% | – |
| Q3 2022 | $44,000 | +37.5% | 36,650 | +5.8% | 0.00% | – |
| Q2 2022 | $32,000 | -48.4% | 34,650 | 0.0% | 0.00% | – |
| Q1 2022 | $62,000 | +17.0% | 34,650 | 0.0% | 0.00% | – |
| Q4 2021 | $53,000 | -30.3% | 34,650 | -8.0% | 0.00% | – |
| Q3 2021 | $76,000 | -46.1% | 37,650 | -7.0% | 0.00% | – |
| Q2 2021 | $141,000 | +7.6% | 40,500 | -45.3% | 0.00% | – |
| Q1 2021 | $131,000 | +142.6% | 74,000 | +41.0% | 0.00% | – |
| Q4 2020 | $54,000 | +980.0% | 52,500 | +950.0% | 0.00% | – |
| Q3 2020 | $5,000 | +400.0% | 5,000 | +400.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |